CONVULEX 150mg gastro-resistant soft capsules LANNACHER
Active substance: valproic acid + salts
N03AG01 Nervous system | Antiepileptics | Antiepileptics | Fatty acid derivatives
Indicated for: epilepsy; bipolar disorder
Find medicines for human use by name or active substance.
Browse by initial
1,441–1,460 of 1,627 medicines
Active substance: valproic acid + salts
N03AG01 Nervous system | Antiepileptics | Antiepileptics | Fatty acid derivatives
Indicated for: epilepsy; bipolar disorder
Active substance: valproic acid + salts
N03AG01 Nervous system | Antiepileptics | Antiepileptics | Fatty acid derivatives
Indicated for: epilepsy; bipolar disorder
Active substance: valproic acid + salts
N03AG01 Nervous system | Antiepileptics | Antiepileptics | Fatty acid derivatives
Indicated for: epilepsy; bipolar disorder
Active substance: valproic acid + salts
N03AG01 Nervous system | Antiepileptics | Antiepileptics | Fatty acid derivatives
Indicated for: epilepsy; bipolar disorder
Active substance: valproic acid + salts
N03AG01 Nervous system | Antiepileptics | Antiepileptics | Fatty acid derivatives
Indicated for: epilepsy; bipolar disorder
Active substance: valproic acid + salts
N03AG01 Nervous system | Antiepileptics | Antiepileptics | Fatty acid derivatives
Indicated for: epilepsy; bipolar disorder
Active substance: glatiramer acetate
Indicated for: multiple sclerosis
Active substance: glatiramer acetate
Indicated for: multiple sclerosis
Active substance: glatiramer acetate
Indicated for: multiple sclerosis
Active substance: glatiramer acetate
Indicated for: multiple sclerosis
Active substance: ribavirin
Indicated for: chronic hepatitis C
Active substance: levodopa + carbidopa + entacapone
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
Active substance: levodopa + carbidopa + entacapone
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
Active substance: levodopa + carbidopa + entacapone
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
Active substance: levodopa + carbidopa + entacapone
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
Active substance: levodopa + carbidopa + entacapone
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
Active substance: levodopa + carbidopa + entacapone
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.